Corridor Pharmaceuticals corridorpharma.com

Corridor Pharmaceuticals, formerly Arginetix, is a platform-based pulmonary and critical care company focused on developing therapeutics to treat inflammation, fibrosis and endothelial dysfunction. Utilizing their platform technology, the Company has discovered a highly potent, small molecule approach to inhibiting arginase. Corridor is targeting diseases where elevated arginase levels have been shown to be involved in disease progression such a pulmonary fibrosis, COPD and ischemia reperfusion ...Show all

Corridor Pharmaceuticals, formerly Arginetix, is a platform-based pulmonary and critical care company focused on developing therapeutics to treat inflammation, fibrosis and endothelial dysfunction. Utilizing their platform technology, the Company has...Show all

Company (Alive / Active)

All investors data 9 Investors

• Acidophil
• Ben Franklin Technology Partners of Central & Northern PA
• Ben Franklin Technology Partners of Southeastern PA
• Domain Associates
• Maryland Health Care Product Development Corporation

Competitors

Patents